| Having trouble viewing this email? Click here |
![]() |
||||
| Advancing and protecting our clients' interests in the pharmacy benefit marketplace for more than 20 years. | ||||
|
SUMMARY OF TOP ARTICLES - OCTOBER 9, 2014
Celebrating Pharmacists: Core Part of Your Health Care Team Pharmacy Times - October 1, 2014 October is American Pharmacists Month, and the American Pharmacists Association (APhA) wants you to “Know Your Pharmacist—Know Your Medicine.” Pharmacists need to adapt for patients with multiple chronic illnesses Pharmaceutical Society of Australia - October 3, 2014 Pharmacy practice needs adapt to meet the challenges of an increased complexity of healthcare and medication which is a result of increasing numbers of people living with multiple chronic health conditions. Lilly Discontinues Lupus Drug Development Based on Disappointing Results Pharmacy Times - October 3, 2014 Eli Lilly and Company has discontinued development of its experimental systemic lupus erythematosus (SLE) treatment, tabalumab, given the drug failed to establish efficacy in 2 pivotal late-stage trials. Officials Question the Rising Costs of Generic Drugs New York Times - October 7, 2014 The prices of some generic drugs have soared more than 1,000 percent in the last year, and federal officials are demanding that generic drug makers explain the reasons for the increases or potentially face new regulation. New Drug-Delivery Capsule May Replace Injections MIT News - October 1, 2014 Given a choice, most patients would prefer to take a drug orally instead of getting an injection. Unfortunately, many drugs, especially those made from large proteins, cannot be given as a pill because they get broken down in the stomach before they can be absorbed. Experimental Ebola Drug Puts Its Maker, Chimerix, Back in the Spotlight New York Times - October 7, 2014 Just seven months ago, executives at the biotechnology company Chimerix were receiving death threats after refusing to provide its experimental drug to a 7-year-old boy who was close to dying from a viral infection. Osteoporosis Treatment May also Benefit Breast Cancer Patients McGill University Health Centre - October 3, 2014 Treatment approaches to reduce the risk of bone complications (metastasis) associated with breast cancer may be one step closer to becoming a reality. Access wanted: What it takes for patients to get the drugs they need BioPharmaDive - September 30, 2014 Part 1 of a 2-part series on health technology assessment and patient access. Cancer therapy: Driving cancer cells to suicide ScienceDaily - September 30, 2014 A new class of chemical compounds makes cancer cells more sensitive to chemotherapeutic drugs, researchers report. They have also pinpointed the relevant target enzyme, thus identifying a new target for anti-tumor agents. Data Show $1B in Physician Payments Withheld From New Database iHealthBeat - October 7, 2014 CMS' recently launched physician payment website is missing more than $1 billion in payments made by drugmakers and medical device manufacturers to health care providers, according to a CMS factsheet, ProPublica reports. Nobel Prize for medicine goes to discoverers of brain’s 'inner GPS' Reuters - October 6, 2014 British-American John O'Keefe and Norwegians May-Britt and Edvard Moser won the 2014 Nobel Prize for medicine for discovering the brain's navigation system and giving clues as to how strokes and Alzheimer's disrupt it. The case for a limited distribution model American Pharmacists Association - October 1, 2014 During a pharmacy and therapeutics committee meeting, discussion about new, high-cost hepatitis C treatments prompted me to consider the role of specialty pharmacy (SP) within the industry as a whole. Medicare Fines 2,610 Hospitals In Third Round Of Readmission Penalties Kaiser Health News - October 2, 2014 Medicare is fining a record number of hospitals – 2,610 – for having too many patients return within a month for additional treatments, federal records released Wednesday show. Flu vaccinations delayed due to supply issues Drug Topics - October 6, 2014 Some pharmacies and health clinics in the United States and Canada are waiting on quadrivalent influenza vaccine, after production issues this fall. Clinics that had expected to receive the vaccine by mid-September are now forced to wait until mid-October. Contact, Jan Tankersley Senior Vice President, Marketing & Sales Pharmaceutical Strategies Group (PSG) Office: 972-943-7141 Email: JTankersley@PSGConsults.com PSGNewsletter@PSGConsults.com www.PSGConsults.com |
||||